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In the past, there has been considerable
pessimism about our ability to identify the preg
nant patient at risk. However, with the develop
ment of sophisticated diagnostic techniques
these patients can be identified and with appro
priate treatment their outcome can be im
proved. This paper presents the overall benefit
of categorizing obstetrical patients, the method
that has been developed at the Medical College
of Virginia (MCV), and certain categories of
high-risk obstetrical patients who continue to
present problems and have unacceptably high
complication rates.
A variety of systems has recently ap
peared in the literature designed to categorize
the high-risk obstetrical patient' To be success
ful such a system must be accurate and simple
enough to understand. Some of the initial sys
tems of categorization were simply too com
plicated They involved the tabulation of mul
tiple factors drawn from virtually every aspect of
the patient's lifestyle, physical examination, and
laboratory assessment Consequently, they
were too cumbersome to be practical The goal
of any identification system should be to sepa
rate patients into groups which can then be
managed according to the common require
ments of each group.
The classification system used at MCV is
based on the premise that a given pregnancy
may represent a progressive risk to the fetus or
the mother and that this risk can be attenuated
by appropriate care. Not included in the system
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are patients at risk for congenital anomalies.
This group of patients undergoes comprehen
sive early antenatal evaluation. The results of
this evaluation are then made available to the
parents. who in turn determine what action is to
be taken. On the other hand, there is a larger
group of patients whose pregnancies are at pro
gressive risk in utero. Identification, classifica
tion and appropriate intervention can improve
perinatal outcome in this larger group.
The MCV identification system is divided
into four categories. It was recognized at the
outset that obstetrical patients could not simply
be separated into normal patients and high-risk
patients If this were done, 90% of the patients
would be in the high-risk category and only
1 0% in the normal category Instead, it seemed
more logical to group patients according to the
severity of their problems.
Class IV Critical care pregnancies
Eclampsia
Severe preeclampsia
Chronic hypertension with superim
posed preeclampsia
Chronic renal disease uncompensated
(creatinine 1 .2 mg/% or greater)
Organic heart disease uncompensated
(early signs of failure)
Hemoglobinopathies in crisis
Pyelonephritis, acute
Premature rupture of the membranes
Premature dilatation of the cervix in the
second half of pregnancy
Diabetes (ketonuria)
Placental accidents (abruptio placenta

and placenta previa in the second
half of pregnancy)
Class Ill High-risk pregnancy
Mild preeclampsia
Diabetes without evidence of ketonuria
Chronic hypertension
Chronic renal disease compensated
(creatinine less than 1.2 mg/%)
Organic heart disease compensated
(no signs of failure)
Hemoglobinopathy, disease stable
(hemoglobin less than 10 gm%)
Rhesus negative, sensitized
Previous intrauterine fetal demise in
second half of pregnancy
Proven intrauterine growth retardation
Maternal weight loss
Gestational age documented greater
than 4 2 weeks
Multiple pregnancy
Maternal weight greater than 300
pounds
Deficiency anemias (hemoglobin less
than 10 gm/%)
Class II At-risk pregnancy
Maternal weight between 250 and 300
pounds
Hemoglobinopathy, trait (hemoglobin
10 gm/% or greater)
Deficiency anemias (hemoglobin 10
gm/% or greater)
History of urinary tract infections
Bacteriuria
Rhesus negative, unsensitized
Suspected intrauterine growth retardation
Inadequate maternal weight gain
Previous cesarean section
Previous premature baby
Previous baby 10 pounds or greater
Class I Normal pregnant patients
Critical care pregnancies (Class IV) are
those pregnancies in which there is an imminent
possibility of decompensation. As is apparent
from the diagnoses, there is a risk of death to
the fetus or the mother. These patients should
generally be cared for in the hospital.
High-risk pregnancies (Class Ill) include
those that are not quite as critical as the Class
IV type but whose diagnoses carry an unaccep
tably high perinatal loss. This is the category at
which all the "new" antepartum testing tech-

niques and methods of management have been
directed. Specialized high-risk obstetrical clinics
have been developed in referral centers to eval
uate and closely follow patients in this category.
The most substantial improvement in perinatal
outcome can be realized in the Class Ill cate
gory.
At-risk pregnancies (Class II) need to be
identified but do not require specialized surveil
lance. From the nature of the diagnoses it is ap
parent that all these patients have the capacity
to decompensate and therefore require close
supervision.
Low-risk pregnancies (Class I) include pa
tients with normal pregnancies Frequently, the
least number of patients are found in this cate
gory. These are patients with normal histories,
normal physical examinations and normal labo
ratory values. Their pregnancies follow the pro
jected course for fundal growth, maternal
weight gain, blood pressure, and all other pa
rameters of normal pregnancy.
It is important to note that the assignment
of a classification does not mean that the pa
tient is necessarily going to remain in that classi
fication throughout the pregnancy. Patients may
shift from one class to another as their status
improves or worsens. For example, if a patient
has an iron deficiency anemia with hemoglobin
of 11 gm/% she is placed in the Class II cate
gory. She is counseled about nutrition and ap
propriate diet, and iron supplements are pre
scribed. If, however, her hemoglobin drops to 9
gm/% as her pregnancy progresses, she is
then placed in the Class Ill category. This may
mean that she is transferred from a routine ob
stetrical clinic to a high risk clinic with special
ized surveillance.
There are several diagnoses contained in
the classification system that are of special in
terest. One such diagnosis is maternal weight
loss (Class Ill).
In the past, not enough attention has been
paid to adequate weight gain in pregnancy. A
great deal of emphasis has been placed on ex
cessive weight gain yet poor weight gain or
worse, weight loss, has not been so readily rec
ognized. It is important to realize that the corre
lation between low-birth-weight infants and lack
of maternal weight gain is greater than with any
other single factor. When charts are examined
retrospectively for factors such as parity, so
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emia, renal disease. cigarette smoking, and
number of children, the greatest influence on
fetal weight gain is maternal weight gain.
Poor fetal weight gain is not necessarily
due to the fact that the mother's nutritional
status is inadequate. Maternal weight gain is
predicted both on her nutritional status and on
the size of her fetus. If there is a problem pre
venting the growth of the fetus, such as rubella,
the mother will not gain weight. This mother can
be fed an adequate diet. but the baby will not
grow because of its limited potential. Decreased
maternal weight may cause poor fetal growth,
but the reverse is also true. Poor fetal growth
may be responsible for limited maternal weight
gain.
Suspected intrauterine growth retardation
(IUGR) is another category that deserves special
attention because of the difficulty of diagnosis.
Suspected intrauterine growth retardation, as
measured by biparietal diameter with ul
trasound, is often an iatrogenic problem Er
roneous measurements. or studies done too fre
quently, may indicate that there is lack of
growth in the biparietal diameter. This points to
the possibility of placental or fetal compromise.
although, in fact. it may be nothing more than
laboratory error.
Intrauterine growth retardation diagnosed
prior to 28 weeks gestation should be extremely
suspect. Even in placental insufficiency syn
dromes. the fetal head usually continues to
grow past 28 weeks, and it is extremely unlikely
that the diagnosis of IUGR can be made from
biparietal diameter data before that time. A
biparietal diameter four or more weeks behind
the dates prior to 28 weeks usually indicates
"wrong dates."
Hypertensive disorders in pregnancy are
important because of their frequency and be
cause of the profound effects they have both on
the mother and the fetus. They are divided into
the toxemias (eclampsia and preeclampsia).
chronic hypertension, gestational hypertension,
and toxemia superimposed on hypertension.
Gestational hypertension is hypertension that is
unmasked in pregnancy but without the criteria
for the diagnosis of toxemia.
Making the appropriate diagnosis of hy
pertensive disorders in pregnancy can be con
fusing. However, high blood pressure, regard
less of etiology, has a deleterious effect on the
end organs, be it the brain. the liver, the kidney,
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the cardiovascular system or the placenta.
While it is important to establish a diagnosis, it ist
more important to realize that the magnitude o�
the blood pressure and the extent of end organ
damage is directly proportional to fetal-maternal
morbidity and mortality. In a series of hyperten"
sives with proteinuria, the perinatal mortality,
rate was 3 7. 9 per 1000 births. This compared
with a rate of 17.2 per 1000 for normotensive
patients without proteinuria. 2 In patients with·
diastolic blood pressure greater than 120, the
perinatal mortality is 50%. 3
Hypertensive syndromes in pregnancy,
continue to result in maternal mortality The out
come is compromised particularly if accelerated:
hypertension occurs in the third trimester. Gen
erally this is categorized as chronic hyper
tension with superimposed toxemia.' Chesley
reports that hypertension is rarely aggravated in
pregnancy unless there is significant cardiac,
renal, or retinal pathology.• What must be em
phasized. however, is that this type of pathol
ogy is fairly common in hypertensives and when
these women become pregnant they are at in
creased risk.
In the past several years much attention
has been directed at predicting the patient who
will develop hypertension in pregnancy. Dalton
looked at weight gain as an indicator. 6 She re
ported the incidence of preeclampsia to be
26% in patients who gained more than 1 %
pounds per week after the 30th week of gesta
tion. The weight gain she is alluding to is not
really caloric weight gain but rather fluid reten
tion which is one of the triad of symptoms asso
ciated with preeclampsia Edema. however.
does not correlate well with increased perinatal
morbidity and mortality. In fact, fluid retention is
the least significant of the triad of hypertension,
proteinuria and edema in relationship to peri
natal mortality. 3 Chesley has demonstrated that
the diastolic blood pressure is the most signifi
cant factor in patients who will develop hyper
tension in pregnancy. 5 In his study, diastolic ele
vation occurred as the first symptom in 58% of
patients whereas proteinuria occurred as the
first symptom in only 34%. Proteinuria is only a
reflection of the end organ damage to the kid
ney in hypertensives. In toxemia the vascular
changes resulting in decreased perfusion of vi
tal organs is frequently long standing prior to a
noticeable elevation in the diastolic blood pres
sure. Indeed, Gant and others' have demon-

strated that the vascular changes typical of tox
emia occur as early as 24 weeks. Using 140/
90 as a standard, the physician may not be
able to appreciate an elevation until 35 or 36
weeks when end organ damage is already sub
stantial. If the diastolic blood pressure is 75-85
mm Hg, the perinatal mortality is about 7 per
1000. As the diastolic pressure increases to
85-90 mm Hg the rate is 10 per 1000. When
the diastolic is 90-104 mm Hg, the perinatal
mortality triples what it was at 75 mm Hg and
there is a progressive linear increase in perinatal
mortality as the diastolic blood pressure contin
ues to elevate.' A diastolic reading of 90 mm
Hg at any point in pregnancy is distinctly abnor
mal.
Calculation of the mean arterial pressure
(MAP) is the most sensitive method of predicting
impending hypertension in pregnancy. This
measurement is obtained using the following
formula.
Systolic + 2 Diastolic
MAP =
3
A MAP greater than 90 in the second trimester
or greater than 105 in the third trimester is
prognostic of hypertension, either gestational
hypertension or toxemia.•
Page and Christianson calculated MAP in
the second and third trimesters and correlated it
with outcome.• They found that when the MAP
went from 90 to 95 or greater, the incidence of
preeclampsia tripled. It is important to note that
a blood pressure of 140/90 yields a MAP of
well over 100. A blood pressure reading that
may appear grossly normal is often abnormal
when calculating its mean arterial pressure.
Diabetes in pregnancy, while it represents
a much smaller proportion of patients than the
hypertensives, continues to be a problem. Dia
betic pregnancies carry a perinatal death rate
four to five times higher than normal preg
nancies.• The outcome depends largely on the
severity of the diabetes and the amount of vas
cular disease present prior to pregnancy. Some
of the common problems seen in these preg
nancies are congenital anomalies (6%), oligohy
dramnios, premature rupture of membranes,
macrosomia, toxemia (13% to 50%), urinary
tract infections, increased incidence of cesa
rean section, birth trauma and intrauterine
deaths. In addition, babies of diabetic mothers
experience many problems in the newborn nur-

sery. They include hypoglycemia, respiratory
distress syndrome, and hyperbilirubinemia.
The key to improved outcome in diabetic
pregnancies centers around early diagnosis and
strict metabolic control. Patients with a family
history of diabetes or macrosomic babies,
(greater than 4000 grams) should have a glu
cose tolerance test to screen for diabetes. In
women who have had a previous baby weighing
more than 4000 grams, 10% have undiag
nosed diabetes. ' 0 These women have high
blood sugars which stimulate the fetal pancreas
to produce insulin. Insulin acts like growth hor
mones in the fetus resulting in macrosomia.
Glycosuria in pregnancy is another indicator to
screen for diabetes. It cannot be dismissed as a
decreased renal threshold for glucose or as ga
lactosuria secondary to breast development.
Any patient with glycosuria in pregnancy should
be considered diabetic until proven otherwise.
Finally, patients with a poor obstetrical his
tory should be screened for diabetes. This in
cludes previous congenital anomalies, stillbirth,
and repeated pregnancy loss.
In conclusion, the classification system
developed at the Medical College of Virginia to
identify the high-risk gravida has been pre
sented with a discussion of some of the prob
lems in pregnancy that carry a high perinatal
mortality. The importance of classifying patients
according to risk is emphasized so that appro
priate management can ensue. In this way,
pregnancy outcome can be improved.
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